Platelet Aggregates in Ischemic Heart Disease

Keywords

Platelets - Platelet aggregates - Myocardial ischemia - Unstable angina

• References

• 1 O'Brien JR, Heywood JB, Heady OA. The quantitation of platelet aggregation induced by four compounds: A study in relation to myocardial infraction. Tromb Diath Haemorrh 1966; 16: 752-767
• 2 Zahavi J, Dreyfuss F. An abnormal pattern of adenosine diphosphate-induced platelet aggregation in acute myocardial infarction. Thromb Diath Haemorrh 1969; 21: 76-88
• 3 Dreyfuss F, Zahavi J. Adenosine diphosphate-induced platelet aggregation in myocardial infarction and ischemic heart disease. Atherosclerosis 1973; 17: 107-120
• 4 Handin RL, McDonough M, Lesch M. Elevation of platelet factor four in acute myocardial infarction: Measurement by radioimmunoassay. J Lab Clin Med 1978; 91: 340-349
• 5 Ellis EF, Oelz O, Roberts LJ, et al. Coronary arterial smooth muscle contraction by a substance released from platelets: Evidence that it is thromboxane A₂ . Science 1976; 193: 1135-1137
• 6 Needleman P, Kulkarni PS, Raz A. Coronary tone modulation: Formation and actions of prostaglandins, endoperoxides, and thromboxanes. Sciene 1977; 194: 409-412
• 7 Lewy RI, Smith JB, Silver MJ, Weiner L, Walinsky P. Detection of thromboxane B₂ in peripheral blood of patients with Prinzmetal’s angina. Prostaglandins Medicine 1979; 2: 243-246
• 8 Shimamoto T, Kobayishi M, Takahashi T, Numano F, Morooka S. Myocardial infarction experimentally induced by thromboxane A₂ . Circulation 1977; 56: 111-123
• 9 Smythe HA, Ogryzlo MA, Murphy EA, Mustard JF. The effect of sulfinpyrazone (anturane) on platelet economy and blood coagulation in man. Can Med Assoc J 1956; 92: 818-821
• 10 The Anturane Reinfraction Trial Research Group Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. New Engl J Med 1978; 298: 289-295
• 11 Wu KK, Hoak JC. A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 1974; ii: 924-926
• 12 Dougherty J, McIntyre N, Weksler BB. Assessment of platelet activation in relation to acute thrombotic events. Blood 1975; 46: 1021
• 13 Gryglewski RJ, Szczeklik A, Nizankowski R. Antiplatelet action of intravenous infusion of prostacyclin in man. Thrombos Res 1978; 13: 153-163
• 14 Pierson ES, Hartley OH. Biometric tables for statistics, Vol 1. Cambridge, Engl: Cambridge University Press: 1972. p. 117
• 15 Feller W. An introduction to probability and its applications. 3rd edition New York: John Wiley: 1975. p. 110
• 16 Mehta J, Mehta P, Pepine CJ. Platelet aggregation in aortic and coronary venous blood in patients with and without coronary disease. Circulation 1978; 58: 881-886
• 17 Tukey JW. Some thoughts on clinical trials, especially problems of multiplicity. Science 1978; 198: 679-684
• 18 Chandler AB, Chapman I, Erhardt LR, et al. Coronary thrombosis in myocardial infarction. Am J Cardial 1974; 34: 823-833
• 19 Vetter NJ, Strange RC, Adam W, Oliver ME. Initial metabolic and hormonal response to acute myocardial infarction. Lancet 1974; 1: 284-289
• 20 Prazich JA, Rapaport SI, Samples JR, Engler R. Platelet aggregate ratios-standardization of technique and test results in patients with myocardial ischemia and patients with cerebrovascular disease. Thromb Haemostas (Stuttg) 1977; 38: 597-605
• 21 Hoak J. Discussion. In: Platelet Function Testing. Day JH, Holmsen H, Zucker MB. eds (DHEW Publication No. (NIH) 78-1087) Washington, D C: Government Printing Office: 1978: 432
• 22 Weksler B. Discussion. In: Platelet Function Testing. Day HJ, Holmsen H, Zucker MB. eds (DHEW Publication No. [NIH] 78-1087) Washington, DC: Government Printing Office: 1978: 432
• 23 Rohrer TF, Pfister B, Weber C, Imhof PR, Stucki P. Validity of the Wu and Hoak Method for the quantitative determination of platelet aggregation in vivo . Blut 1978; 36: 15-20
• 24 Folts JD, Crowel EB, Rowe GG. Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation 1976; 54: 365-370